Pharmacist's role in controlling glucose levels in patients using insulin in the Unified Health System
- Conditions
- Diabetes MellitusC23.550.291.500
- Registration Number
- RBR-7v2jnwr
- Lead Sponsor
- niversidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Patients with type 2 diabetes mellitus (DM2); who use Hagedorn's neutral protamine insulin (NPH) and/or regular insulin; who collect these medicines from the Municipal Pharmacy of Ijuí; between 35 and 70 years old; with autonomy to use medications and apply insulin; who do not need a caregiver; with changes in capillary blood glucose previously measured in a pharmacist's office (blood glucose levels above 180 mg/dL at any time of the day).
Patients with type 1 diabetes mellitus (DM1); pregnant women; under 35 years old and over 70 years old; with circumstances that do not allow filling out the questionnaires (inability to speak, see or hear); those with a medical diagnosis of cognitive impairment; those that are banned; those who do not agree to participate in the research; those who do not sign the Free and Informed Consent Form (TCLE).
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected to find a reduction in glycated hemoglobin, found in the method Fajriansyah et al. 2020, of at least 0.5%, when comparing the patient himself from the beginning to the end of the six months of intervention.
- Secondary Outcome Measures
Name Time Method It is expected to find an average reduction in glycemia between the groups, found in the method of Javaid et al. 2019, of at least 1.18 mg/dL.